Jun 01, 2017 8:00 am EDT Capricor Therapeutics to Present at the LD Micro Invitational Conference on June 6
May 31, 2017 7:00 am EDT Capricor Therapeutics Announces Upcoming Events in Duchenne Muscular Dystrophy Program
May 25, 2017 9:00 am EDT Capricor Therapeutics Announces Formation of Duchenne Muscular Dystrophy Advisory Board
May 15, 2017 4:15 pm EDT Capricor Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 04, 2017 4:00 pm EDT Capricor Therapeutics to Hold First Quarter 2017 Financial Results and Corporate Update Conference Call on Monday, May 15
Apr 26, 2017 8:00 am EDT Capricor Therapeutics to Present at the Alliance for Regenerative Medicine's Cell & Gene Therapy Investor Day
Apr 25, 2017 6:00 am EDT Capricor Therapeutics Announces Positive Six-Month Results from the Randomized Phase I/II HOPE Clinical Trial in Duchenne Muscular Dystrophy
Apr 24, 2017 4:30 pm EDT Capricor Therapeutics to Report Six-Month Results from the Randomized Phase I/II HOPE Clinical Trial in Duchenne Muscular Dystrophy